Objective: To determine safe and appropriate alarm limits for the Marquette 8000 pulse oximeter to prevent hyperoxic and hypoxic episodes in neonates. It is necessary to define these limits for each brand of oximeter because of the variance in nonuser adjustable calibration algorithms used in pulse oximeters. Methodology: Oxygen saturation values obtained from a Marquette 8000 pulse oximeter (SpO(2)) were compared with simultaneous arterial brood gas PaO2 values obtained from blood gas analysis, for 322 samples in 24 consecutive neonates (median 30 weeks' gestation). Results: In order to prevent 95% of hyperoxic episodes (PaO2 > 90 mmHg), the upper alarm limit was 95% SpO(2) Similarly, to prevent 95% of hypoxic episodes (PaO2 < 40 mmHg), th...
Recent guidelines recommend oxygen saturation (SpO) levels of 90%-95% for preterm neonates on supple...
Objective We aimed to test whether the use of novel pulse oximetry sounds (sonifications) better inf...
This article reviews the development of the Ninth Clinical Consensus Statement by SIBEN (the Ibero-A...
Pulse oximetry has been proposed as a noninvasive continuous method for transcutaneous monitoring of...
OBJECTIVE. The objective of this study was to determine the rate of compliance with hospital guideli...
Objective: To investigate the effect of different pulse oximetry (SpO2) target range settings during...
We tested the hypothesis that hyperoxemia defined as arterial PO2 above 12 kPa can be detected by pu...
Monitoring and maintaining premature neonates’ oxygen saturation (SpO2) levels within the recommende...
Pulse oximetry has recently been introduced as a method for continuous and non-invasive transcutane...
Abstract Background Changes in oxygen saturation (SpO2) exposure have been shown to have a marked im...
Purpose: To determine the effect of changing practice guidelines designed to avoid hyperoxia or hypo...
BackgroundWe compared our clinical experience with currently available reference oxygen saturation l...
The optimum range of pulse oximeter oxygen saturation (SpO(2)) for preterm infants remains controver...
Recent guidelines recommend oxygen saturation (SpO(2)) levels of 90%-95% for preterm neonates on sup...
seen when targeting higher saturations with some algorithms (13.3 % vs 21.8%), but not with others (...
Recent guidelines recommend oxygen saturation (SpO) levels of 90%-95% for preterm neonates on supple...
Objective We aimed to test whether the use of novel pulse oximetry sounds (sonifications) better inf...
This article reviews the development of the Ninth Clinical Consensus Statement by SIBEN (the Ibero-A...
Pulse oximetry has been proposed as a noninvasive continuous method for transcutaneous monitoring of...
OBJECTIVE. The objective of this study was to determine the rate of compliance with hospital guideli...
Objective: To investigate the effect of different pulse oximetry (SpO2) target range settings during...
We tested the hypothesis that hyperoxemia defined as arterial PO2 above 12 kPa can be detected by pu...
Monitoring and maintaining premature neonates’ oxygen saturation (SpO2) levels within the recommende...
Pulse oximetry has recently been introduced as a method for continuous and non-invasive transcutane...
Abstract Background Changes in oxygen saturation (SpO2) exposure have been shown to have a marked im...
Purpose: To determine the effect of changing practice guidelines designed to avoid hyperoxia or hypo...
BackgroundWe compared our clinical experience with currently available reference oxygen saturation l...
The optimum range of pulse oximeter oxygen saturation (SpO(2)) for preterm infants remains controver...
Recent guidelines recommend oxygen saturation (SpO(2)) levels of 90%-95% for preterm neonates on sup...
seen when targeting higher saturations with some algorithms (13.3 % vs 21.8%), but not with others (...
Recent guidelines recommend oxygen saturation (SpO) levels of 90%-95% for preterm neonates on supple...
Objective We aimed to test whether the use of novel pulse oximetry sounds (sonifications) better inf...
This article reviews the development of the Ninth Clinical Consensus Statement by SIBEN (the Ibero-A...